Tag: RAPIDAI

Rapid ich

Rapid ICH receives new US FDA clearance with “highest sensitivity and...

RapidAI has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the latest release of Rapid ICH—a technology that it describes as...

RAPID Aneurysm programme shows positive early performance in retrospective study

RAPID Aneurysm, a semi-automated artificial intelligence (AI) software programme (RapidAI), is highly accurate in detecting cerebral aneurysms on computed tomography angiography (CTA) imaging, according...
Rapid ich

RapidAI receives US FDA clearance for Rapid Hyperdensity

RapidAI has announced receipt of US Food and Drug Administration (FDA) clearance for Rapid Hyperdensity—the newest addition to the RapidAI platform. According to the company,...

RapidAI announces Karim Karti as new CEO

RapidAI has announced Karim Karti, former president and CEO of GE Healthcare Imaging, as the company’s chief executive officer (CEO). “Karim’s tremendous global experience in...
Rapid ich

RapidAI unveils prehospital solution to optimise cross-team workflow and improve patient...

RapidAI has announced the launch of its Rapid prehospital workflow solution for stroke, which optimises coordination between emergency medical services (EMS) providers and hospital...
rapidAI Rapid LVO FDA approval

RapidAI experiences nearly 300% growth

RapidAI, a neuroimaging stroke software platform which uses artificial intelligence (AI), has announced growth of nearly 300%. This has been attributed by RapidAI in...
rapidAI Rapid LVO FDA approval

RapidAI announces software approval for Medicare New Technology Add-on Payment

RapidAI states Rapid LVO is among the first software products to qualify for the New Technology Add-on Payment (NTAP). NTAP is part of the CMS...